Metabolomics Services Market Report 2024

This Metabolomics Services market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The metabolomics services market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The growth observed during the historic period can be attributed to several factors, a heightened emphasis on biomarker discovery, a growing demand for sophisticated diagnostic tools, increased use in agricultural research, a rise in the number of clinical trials, and greater awareness of the applications of metabolomics.

The metabolomics services market size is expected to see rapid growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth during the forecast period can be linked to several factors, the rising prevalence of cancers, growing demand for personalized medicine, expanding applications in life sciences and biotechnology, increasing disease burden, and advancements in healthcare infrastructure. Key trends expected during this period include technological innovations, the use of machine learning, advancements in bioinformatics tools, integration of artificial intelligence, and the development of new diagnostic tools.

The growing demand for personalized medicine is anticipated to drive the expansion of the metabolomics services market. Personalized medicine tailors healthcare decisions and treatments to individual patients based on their genetic profiles, environmental factors, and lifestyle choices. This rising demand is fueled by advancements in genomic technologies, which enable more precise and customized treatments, as well as an increased focus on individualized patient care for improved outcomes. Metabolomics services support personalized medicine by offering detailed metabolic profiles that help in customizing treatments according to each patient's unique biochemical state, resulting in more effective and targeted therapies. For example, the Personalized Medicine Coalition, a US-based professional organization, reported that in 2022, 12 new personalized medications were approved, representing about 34% of all newly approved treatments, marking a notable increase from previous years. Consequently, the surge in personalized medicine demand is propelling the growth of the metabolomics services market.

Leading companies in the metabolomics services market are advancing diagnostic tools to improve disease detection and support personalized medicine. These diagnostic tools are used to identify and evaluate medical conditions, helping healthcare professionals make accurate diagnoses and inform treatment decisions. For instance, in October 2023, Sapient Bioanalytics LLC, a US-based biotechnology firm, introduced target metabolite and lipid panels for biomarker discovery and rapid insights. These panels focus on identifying and quantifying specific metabolites and lipids, which enhances biomarker detection precision. Designed for quick results, these panels include advanced data analysis tools to interpret complex metabolic profiles and provide actionable insights, crucial for timely decision-making in both research and clinical environments.

In October 2022, Clinical-Microbiomics A/S, a Denmark-based company specializing in metabolome and microbiome analysis, acquired MS-Omics ApS for an undisclosed amount. This acquisition is aimed at strengthening Clinical-Microbiomics’ capabilities in microbiome research and expanding its range of omics services by incorporating MS-Omics’ expertise in mass spectrometry-based proteomics and metabolomics. MS-Omics ApS is a Denmark-based firm that provides metabolomics analysis services.

Major companies operating in the metabolomics services market are BASF SE, Waters Corporation, Bruker Corporation, RTI International, SCIEX, BGI Group, Fred Hutchinson Cancer Research Center, OWL Inc., LECO Corporation, Metabolon Inc., MetaSysX Inc., Nightingale Health, Biocrates Life Sciences AG, Human Metabolome Technologies America Inc., CosmosID, Centre for Cellular and Molecular Platforms, Creative Proteomics, Cogentech, Stemina Biomarker Discovery Inc., Thermal Management Innovations Corporation, Afekta Technologies Ltd., MS-Omics, Clinical Microbiomics, DNA Xperts Private Limited, Metware Biotechnology Co. Ltd.

North America was the largest region in the metabolomics services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metabolomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Metabolomics services involve analytical and technological methods used to examine the metabolites present in a biological system. Metabolites are small molecules resulting from cellular processes, and analyzing them offers insights into the physiological condition of an organism. This approach is valuable for exploring disease mechanisms, identifying biomarkers, and enhancing drug development and personalized medicine.

There are two primary types of metabolomics services such as untargeted and targeted metabolomics. Untargeted metabolomics encompasses a broad analysis of all detectable metabolites in a sample without specific targets in mind. Various products and services available in this field include metabolomics bioinformatics, chromatography, mass spectrometry, and others. These services cater to diverse end-users, such as those in agriculture, food, biomedical and pharmaceutical industries, academic and research institutions, diagnostic labs, and more.

The metabolomics services market research report is one of a series of new reports that provides metabolomics services market statistics, including metabolomics services industry global market size, regional shares, competitors with a metabolomics services market share, detailed metabolomics services market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics services industry. This metabolomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolomics services market includes revenues earned by entities through metabolite identification, custom assay development, and metabolic profiling, and related nuclear magnetic resonance (NMR) spectroscopy systems, sample preparation kits, biomarker panels, and analytical platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.